Pharma’s content supply chain has become overstretched. As the number of channels and requests for content increases, so do the requirements for brand supervision, MLR approvals, production costs, and localisation efforts.
These internal structures and processes are now breaking down – creating backlogs and bottlenecks. What is needed is a supply chain that meets today’s content volume demands.
This whitepaper explains how to do it. 
